Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Supreme Court to Hear Bayh-Dole Lawsuit

February 24, 2011 6:57 am | News | Comments

A Stanford lawsuit that began as a patent infringement case against a drug company has evolved into a dispute over a federal law that promotes the commercialization of government-sponsored research and protects ownership rights of universities to inventions arising from government-sponsored research.


Biovail-Valeant Merger Contributes to Q4 Hardship

February 24, 2011 6:53 am | News | Comments

Costs associated with the recent amalgamation of the Biovail and Valeant drug businesses contributed to a $31.1-million net loss in the fourth quarter for Valeant Pharmaceuticals International, Inc.


FDA Likely to Request More Xifaxan Info

February 24, 2011 6:50 am | News | Comments

Salix Pharmaceuticals Ltd. said it will likely have to provide more information to the Food and Drug Administration before gaining expanded approval for Xifaxan as a treatment for non-constipation irritable bowel syndrome.


Mylan 4Q Profit Plummets 38%

February 24, 2011 6:47 am | News | Comments

Generic drug maker Mylan Inc. said that its fourth-quarter profit fell 38 percent on higher costs and charges, but adjusted results meet Wall Street expectations.


Upsher-Smith Expanding Its Recall

February 24, 2011 6:43 am | News | Comments

Upsher-Smith Laboratories is voluntarily expanding its previously announced recall of Jantoven Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010.


Court Overturns $1.67B Humira Judgement

February 24, 2011 6:37 am | News | Comments

Abbott Laboratories said a federal court of appeals has overturned a $1.67 billion judgment against the company related to patents on its best-selling drug Humira, which were challenged by rival Johnson & Johnson.


Rebound Time

February 24, 2011 6:31 am | by Rita C. Peters, Editorial Director | Articles | Comments

President Barack Obama, in his State of the Union address, identified biomedical research a key industry segment in need of "an investment that will strengthen our security, protect our planet, and create countless new jobs for our people.


NGS Software

February 23, 2011 7:47 am | Product Releases | Comments

Accelrys, Inc., a leading scientific informatics software and services company, announced its entrance in the rapidly growing next generation sequencing (NGS) market with the release of the NGS Collection for Pipeline Pilot.


Biologic Analysis Software

February 23, 2011 7:43 am | Drug Discovery & Development, Drug Discovery & Development | Product Releases | Comments

Genedata announced the release of Genedata Biologics, a first-in-class, off-the-shelf software solution for comprehensive data management and analysis of biologics R&D activities.


Sheffield in Exclusive Partnership with Wockhardt

February 23, 2011 7:31 am | News | Comments

Sheffield Bio-Science has formed a strategic alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the exclusive global sales and distribution partner for recombinant insulin manufactured by global Indian biotech Wockhardt.


Quanterix And Novartis Talk Tech Transfer

February 23, 2011 7:25 am | News | Comments

Quanterix Corporation announced that it has entered into an evaluation of agreement with Novartis Diagnostics on the potential use of Quanterix’s Single Molecule Array (SiMoA) platform technology for diagnostic use.


Protein Could Be Building Block for Nanomedicine

February 23, 2011 6:58 am | News | Comments

Researchers have developed a simple method of making short protein chains with spiral structures that can also dissolve in water, these structures could have applications as building blocks for self-assembling nanostructures and as agents for drug and gene delivery.


Retrovirus Causes Cancer by Hijacking Proteins

February 23, 2011 6:53 am | News | Comments

A cancer-causing retrovirus exploits key proteins in its host cells to extend the life of those cells, thereby prolonging its own survival and ability to spread.


HEPLISAV Safety Assessments Completed

February 23, 2011 6:45 am | News | Comments

Dynavax Technologies Corporation announced that the Data Safety Monitoring Board (DSMB) established for Dynavax's two ongoing Phase 3 trials for HEPLISAV has completed its planned safety assessments.


FDA OKs ONGLYZA Label Update

February 23, 2011 6:39 am | News | Comments

Bristol-Myers Squibb Company and AstraZeneca announced that the U.S. Food and Drug Administration has approved the inclusion of data from two clinical studies in an update to the ONGLYZA U.S. Prescribing Information for adult type 2 diabetes patients.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.